Skip banner and top navigation
NHLBI Logo and Link
National Heart, Lung, and Blood Institute: People, Science, Health
 TEXT SIZE: 
 HOME  SITE INDEX  CONTACT US
  
 information for researchers
Link to the National Institutes of Health Link to the Department of Health and Human Services
Skip left side navigation and go to content
 NHLBI Home
 Information for Patients & the Public
 Information for Health Professionals
 Information for Researchers

NHLBI-Supported Research

Research Resources

Population Studies

Scientific Reports

Technology Transfer
 Funding, Training, & Policies
 Clinical Trials
 Networks & Outreach
 News & Events Center
 About NHLBI

Office of Technology Transfer and Development

Vectors and Gene Therapy

I.D.

Technology

Pat. No.
(LINK TO USPTO)

ES-016

Tetracycline-Modulated Bicistronic Mammalian Expression Vector

 

ES-059

Plasmids DNA's for human and mouse TTP and mammalian expression vectors for same

 

HL-006

Use of Chimeric Murine Leukemia Virus LTRs in Expressing Retroviral Vectors

 

HL-016

Genetic Reassortment of Rotaviruses for Production of Vaccine and Vaccine Precursor

4,571,385

HL-062

Retroviral Vectors Containing Internal Ribosome Entry

 

HL-069

Adenovirus Mediated Transfer Of Genes To The Gastrointestinal Tract

 

HL-072

Inhibition of Cell Proliferation Using Antisense Oligonucleotides

 

HL-090

Improved Expression Of Human Multidrug Resistance Genes And Improved Selection

 

HL-116

Adenovirus Mediated Augmentation of Cell Transfection With Unmodified Plasmid Vectors

 

HL-121

Vector Systems For The Generation of Adeno- Associated Virus Particles

 

HL-122

Fusion Proteins Containing Adeno-Associated Virus Rep Proteins

 

HL-133

Novel Retroviral Envelope and LTR and Retroviral Vector Particles

 

HL-135

Gene Therapy to Promote Myocardial Blood Vessel Growth

 

HL-136

Adeno-Associated Virus Capable of Expressing at Least One Globin Gene and Method

 

HL-137

Lipid Vesicles Containing Adeno-Associated Virus Rep Protein For Transgene Integration

 

HL-146

Vector Particles Resistant to Inactivation by Human Serum

 

HL-149

Gene Therapy with Hirudin for Arterial Proliferating Disease

 

HL-153

Vectors Including Foreign Genes and Negative Selective Markers

 

HL-155

Organ Selective In Vivo Gene Transfer

 

HL-156

Promotion and Angiogenesis using Adenoviral-modified endothelial cells and graft

 

HL-161

Molecular Cloning of AAV and Use as a Transduction Vector

 

HL-169

High level production in vitro of human coagulation factor IX from a recombinant Adeno-associated virus.

 

HL-170

Genetically Engineered Endothelial Cells and uses Thereof

 

HL-174

"Method for Development of Localized Cell-mediated Immune Responses by Gene Transfer into Peripheral Blood Monocyte/macrophages for the Treatment of Aids and Other Infections Pathogens"

 

HL-176

Delivery of Therapeutic Agents by Gene Therapy

 

HL-187

Method for Enhancement of Cell-mediated Immune Responses by Gene Transfer into peripheral blood cells

 

HL-188

Molecular Cloning of AAV5 and It's use as a Transduction Vector

 

HL-225

In vivo transduction of ependymal cells with AAV4 vectors

 

HL-226

In vivo of mouse lung with AAV5 vectors

 

HL-230

A chimeric Lentiviral vector with enhanced gene expression.

 

HL-237

Vectors encoding for the interaction domains of proteins can interfere with those protein interactions

 

HL-240

Methods for producing recombinant AAVs in invertebrate cell lines

 

HL-243

Adeno-associated virus (AAV) vector encoding human coagulation factor VIII under transcription control

 

HL-257

Methods for producing recombinant AAVs in invertebrate cell lines

 
 

All inquires should be directed to (301)-402-5579

 

 

Medical Reagents | Gene Therapy | Devices | Research Tools

Skip footer links and go to content

HOME · SEARCH · ACCESSIBILITY · SITE INDEX · OTHER SITES · PRIVACY STATEMENT · FOIA · CONTACT US